These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 487808)
1. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation. Newton J; Szontagh F; Lebech P; Rowe P Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808 [TBL] [Abstract][Full Text] [Related]
2. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women. Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396 [TBL] [Abstract][Full Text] [Related]
4. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Chi IC Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615 [TBL] [Abstract][Full Text] [Related]
5. Five years private practice experience of nulliparous women using copper IUD's. Smith RP; Goresky DM; Etchell DM Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354 [TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
9. Clinical study of a progesterone-releasing intrauterine contraceptive device. Brenner PF; Cooper DL; Mishell DR Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173 [TBL] [Abstract][Full Text] [Related]
10. Preliminary report on a postpartum CuT 200 study, Santiago, Chile. Lavin P; Waszak C; Bravo C Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798 [TBL] [Abstract][Full Text] [Related]
11. Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. French R; Van Vliet H; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Helmerhorst F; Guillebaud J Cochrane Database Syst Rev; 2004; 2004(3):CD001776. PubMed ID: 15266453 [TBL] [Abstract][Full Text] [Related]
12. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Suvisaari J; Lähteenmäki P Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872 [TBL] [Abstract][Full Text] [Related]
13. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability]. Custo GM; Cosmi EV Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352 [TBL] [Abstract][Full Text] [Related]
14. Experience with two different medicated intrauterine devices: a comparative study of the Progestasert and Nova-T. Fylling P; Fagerhol M Fertil Steril; 1979 Feb; 31(2):138-41. PubMed ID: 761675 [TBL] [Abstract][Full Text] [Related]
15. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771 [TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Luukkainen T; Toivonen J Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882 [TBL] [Abstract][Full Text] [Related]
17. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices. Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785 [TBL] [Abstract][Full Text] [Related]
18. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179 [TBL] [Abstract][Full Text] [Related]
19. Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy. French R; Cowan F; Mansour D; Morris S; Hughes D; Robinson A; Proctor T; Summerbell C; Logan S; Guillebaud J Cochrane Database Syst Rev; 2001; (2):CD001776. PubMed ID: 11406007 [TBL] [Abstract][Full Text] [Related]
20. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study. Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]